Iterion Therapeutics   Report issue

For profit Phase 1
Founded: Houston TX United States (2014)

Organization Overview

First Clinical Trial
2018
NCT03459469
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Beta Cat Pharmaceuticals, Inc.